Abstract
Introduction: Disordered coagulation, clot formation and distal limb
ischemia are complications of extracorporeal membrane oxygenation (ECMO)
with significant morbidity and mortality. Medicinal leech therapy
(hirudotherapy) has been attempted in plastic and orthopedic surgeries
to improve venous congestion and salvage ischemic flaps. To our
knowledge this has not been reported in pediatric cardiac surgery or
during ECMO support. We present a complex neonate whose ECMO course was
complicated by distal limb ischemia for whom leech therapy was
attempted. Patient and Intervention: A 2 week-old 2.7 kg infant required
ECMO support secondary to perioperative multiorgan system dysfunction
following repair of critical coarctation and ventricular septal defect.
Despite systemic anticoagulation, his clinical course was complicated by
arterial thrombus, vasopressor-induced vascular spasm and bilateral
distal limb ischemia. Medicinal leech therapy was tried after initially
failing conventional measures. Result: Following the third leech
application, this patient developed significant hemorrhage from the web
space adjacent to the left great toe. An estimated 450 mL of blood loss
occurred and more than 300 mL of blood product transfusions were
required. He ultimately progressed to irreversible systemic end organ
dysfunction and comfort care was provided. Conclusion: The use of
medicinal leech therapy in pediatric cardiac surgery may be considered
to minimize the consequences of advanced limb ischemia and venous
congestion. However, this should be used with caution while patients are
systemically anticoagulated during ECMO support. A directed review is
presented here to assist in determining optimal application and
potential course of therapy.